Sabril (TN) en es it fr

Sabril (TN) Brand names, Sabril (TN) Analogs

Sabril (TN) Brand Names Mixture

  • No information avaliable

Sabril (TN) Chemical_Formula


Sabril (TN) RX_link

No information avaliable

Sabril (TN) fda sheet

Sabril (TN) msds (material safety sheet)

Sabril (TN) Synthesis Reference

No information avaliable

Sabril (TN) Molecular Weight

129.157 g/mol

Sabril (TN) Melting Point

No information avaliable

Sabril (TN) H2O Solubility

55.1 mg/mL

Sabril (TN) State


Sabril (TN) LogP


Sabril (TN) Dosage Forms

Powder (500 mg sachets); Tablet (500 mg)

Sabril (TN) Indication

For use as an adjunctive treatment (with other drugs) in treatment resistant epilepsy, complex partial seizures, secondary generalized seizures, and for monotherapy use in infantile spasms in West syndrome.

Sabril (TN) Pharmacology

Vigabatrin, is an anticonvulsant chemically unrelated to other anticonvulsants. Vigabatrin inhibits the catabolism of GABA. It is an analog of GABA, but it is not a receptor agonist.

Sabril (TN) Absorption

Rapidly absorbed following oral administration. Food may slightly decrease the rate, but not the extent, of absorption.

Sabril (TN) side effects and Toxicity

No information avaliable

Sabril (TN) Patient Information

This medicine may reduce your ability to drive or operate machinery safely. Do not drive or operate machinery until you know how this medicine affects you and you are sure it won't affect your performance. Avoid stopping this medicine suddenly. The dose of this medicine should be gradually decreased over a period of two to four weeks. After months to years of taking this medication, damage to vision may occur. Regular eye examinations should be conducted and notify your doctor if any change in vision occurs.

Sabril (TN) Organisms Affected

Humans and other mammals